Public market insider selling at HEXO (HEXO)

Public market insider selling at HEXO (T:HEXO)

Updated Thursday May 09, 2019 02:40 AM EDT
Adam Miron, a Senior Officer and Director, disposed of 354,916 Common Shares on an indirect ownership basis for registered holder No. 2 Mission Row Inc. at prices ranging from $10.069 to $10.072 between May 7th, 2019 and May 8th, 2019. This represents a $3,574,525 divestment of the company's shares and an account share holdings change of -10.6%.

HEXO is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market. The Company operates with an approximately 300,000 square feet of production capacity. The Company serves the adult-use market under the HEXO brand, while it serves its medical cannabis clients through the Hydropothecary brand. The following are the Company's products under the Hydropothecary brand: Time of Day product line, which includes dried marijuana buds for morning, midday, after dinner and bedtime; Hydrogen (H2) classical medical marijuana line, which includes Papaya Grove, Green Chai and Kush dried marijuana buds, among others; Decarb ready to consume activated marijuana powder; Elixir cannabis oil sublingual spray, as well as Fleur de Lune intimate cannabis oil.

HEXO Insider Holdings Chart

Issuer details as of May 09, 2019 2:40 ET

Latest Price
10.13
1 Day Change
0.80%
52 Week High
11.29
52 Week Low
3.98
QMV ($Mils)
2,133,436,541


Top